ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 959,68
-0,37%
Dow Jones
41 258,68
-0,22%
DAX
22 534,89
-0,59%
Brent Oil
70,265
-0,60%
Bitcoin
81 838,76
-2,20%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vaxcyte Inc (PCVX)

  7. Vaxcyte Inc (PCVX) Actualités

PCVX

Vaxcyte (PCVX)

Vaxcyte Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PCVX
DateHeureSourceTitreSymboleSociété
07/03/202522h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCVXVaxcyte Inc
05/03/202522h10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PCVXVaxcyte Inc
25/02/202522h42Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PCVXVaxcyte Inc
25/02/202522h11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PCVXVaxcyte Inc
25/02/202522h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCVXVaxcyte Inc
25/02/202522h01GlobeNewswire Inc.Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
12/02/202522h05GlobeNewswire Inc.Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025NASDAQ:PCVXVaxcyte Inc
05/02/202514h00GlobeNewswire Inc.Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in InfantsNASDAQ:PCVXVaxcyte Inc
30/01/202522h05GlobeNewswire Inc.Vaxcyte to Present at the Guggenheim SMID Cap Biotech ConferenceNASDAQ:PCVXVaxcyte Inc
07/01/202507h13PR Newswire (US)Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law FirmNASDAQ:PCVXVaxcyte Inc
03/12/202414h00GlobeNewswire Inc.Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in InfantsNASDAQ:PCVXVaxcyte Inc
12/11/202413h30GlobeNewswire Inc.Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult ProgramsNASDAQ:PCVXVaxcyte Inc
05/11/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCVXVaxcyte Inc
05/11/202422h01GlobeNewswire Inc.Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
11/09/202422h05GlobeNewswire Inc.Vaxcyte to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:PCVXVaxcyte Inc
06/09/202422h05GlobeNewswire Inc.Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:PCVXVaxcyte Inc
05/09/202423h08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PCVXVaxcyte Inc
05/09/202405h58GlobeNewswire Inc.Vaxcyte Announces Pricing of $1.3 Billion Public OfferingNASDAQ:PCVXVaxcyte Inc
03/09/202422h01GlobeNewswire Inc.Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:PCVXVaxcyte Inc
03/09/202413h07GlobeNewswire Inc.Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and OlderNASDAQ:PCVXVaxcyte Inc
03/09/202400h40GlobeNewswire Inc.Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and OlderNASDAQ:PCVXVaxcyte Inc
06/08/202422h05GlobeNewswire Inc.Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
24/05/202423h05Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PCVXVaxcyte Inc
08/05/202422h05GlobeNewswire Inc.Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
02/04/202422h05GlobeNewswire Inc.Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PCVXVaxcyte Inc
04/03/202414h30GlobeNewswire Inc.Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in InfantsNASDAQ:PCVXVaxcyte Inc
27/02/202422h01GlobeNewswire Inc.Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:PCVXVaxcyte Inc
15/02/202422h05GlobeNewswire Inc.Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:PCVXVaxcyte Inc
03/02/202400h39GlobeNewswire Inc.Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:PCVXVaxcyte Inc
01/02/202422h05GlobeNewswire Inc.Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceNASDAQ:PCVXVaxcyte Inc
 Showing the most relevant articles for your search:NASDAQ:PCVX

Dernières Valeurs Consultées

FTSE
UKX
FTSE 100
USI
USTECH100
US Tech 100
NYSE
NKE
Nike
EU
DG
Vinci
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
EU
RNO
Renault
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
EU
AF
Air FranceKLM
EU
VIV
Vivendi
NASDAQ
AMZN
Amazon.com
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces